XNYS
HCA
Market cap96bUSD
Oct 08, Last price
445.01USD
1D
1.33%
1Q
9.45%
Jan 2017
501.20%
IPO
1,334.59%
Name
HCA Healthcare Inc
Chart & performance
P/E
14.20
P/S
1.27
EPS
31.33
Div yield, %
0.65%
Shrs. gr., 5y
-7.75%
Rev. gr., 5y
7.97%
Revenues
75.60b
+7.08%
Net income
6.78b
+17.78%
CFO
12.64b
+20.18%
Dividend
Sep 16, 20260.78 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
Key people
Chairman of the Board · since 2019
Michael Cuffe
Executive Vice President, Chief Clinical Officer · since 2022
Jon Foster
Chief Operating Officer, Executive Vice President · since 2023
Michael Marks
Chief Financial Officer, Executive Vice President · since 2024
Jennifer Berres
Senior Vice President, Chief Human Resources Officer · since 2019
Monica Cintado
Senior Vice President of development · since 2025
Sammie Mosier
Senior Vice President, Chief Nurse Executive · since 2021
Michael Mcalevey
Executive Vice President, Chief Legal and Administrative Officer · since 2024
Director · since 2018
Chief Executive Officer, Director · since 2019
Independent Director · since 2025
Robert Dennis
Independent Director · since 2014
Nancy-Ann Deparle
Independent Director · since 2014
Nancy-Ann DeParle
Independent Director · since 2014
Independent Director · since 2021
Independent Director · since 2018
Wayne Riley
Independent Director · since 2012
Andrea Smith
Independent Director · since 2022
Legal address
c/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST
Wilmington, DE 19801
US
Wilmington, DE 19801
US
Headquarters
One Park Plaza
Nashville, TN 37203
US
Nashville, TN 37203
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||